HomeELEV • NASDAQ
add
Elevation Oncology Inc
Previous close
$0.61
Day range
$0.60 - $0.65
Year range
$0.44 - $5.83
Market cap
36.60M USD
Avg Volume
741.98K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 13.23M | 21.14% |
Net income | -12.88M | -21.11% |
Net profit margin | — | — |
Earnings per share | -0.22 | 12.00% |
EBITDA | -13.22M | -21.20% |
Effective tax rate | -0.09% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 103.07M | 8.73% |
Total assets | 106.30M | 6.33% |
Total liabilities | 36.95M | -1.63% |
Total equity | 69.36M | — |
Shares outstanding | 59.12M | — |
Price to book | 0.52 | — |
Return on assets | -29.94% | — |
Return on capital | -31.17% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -12.88M | -21.11% |
Cash from operations | -8.38M | 37.25% |
Cash from investing | -2.87M | 92.46% |
Cash from financing | 10.00K | -62.96% |
Net change in cash | -11.24M | 78.14% |
Free cash flow | -4.10M | 58.77% |
About
Founded
2019
Headquarters
Website
Employees
29
